RhythmAnalytics vs EchoGo Amyloidosis
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
RhythmAnalytics by Biofourmis specializes in the automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for various rhythm disorders. Conversely, Ultromics' EchoGo Amyloidosis is an AI-powered screening tool designed for the early detection of cardiac amyloidosis using echocardiogram video clips. While both are FDA-cleared AI solutions in cardiology, they address different cardiac conditions and utilize distinct diagnostic modalities, making them complementary rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
RhythmAnalytics by Biofourmis is an AI-powered software designed for the automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support. EchoGo Amyloidosis by Ultromics is an AI-powered screening tool that analyzes echocardiogram video clips to aid in the early detection of cardiac amyloidosis.
RhythmAnalytics analyzes single-lead ECG data. EchoGo Amyloidosis analyzes echocardiogram video clips, specifically 2D echocardiograms of an apical four-chamber (A4C) view.
RhythmAnalytics provides automated interpretation of over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, ectopic beats, beat-by-beat morphology computation, and rhythm analysis. EchoGo Amyloidosis provides a diagnostic output of 'suggestive' or 'not suggestive' of cardiac amyloidosis, based on the analysis of echocardiographic markers like ventricular volume, cardiac function, and myocardial movement.
RhythmAnalytics offers a cloud-based API for integration and is compatible with FDA-cleared ECG devices such as Holter, event recorders, and wearable sensors. EchoGo Amyloidosis is a cloud-based SaaS model designed for seamless integration with existing clinical workflows and IT infrastructure, including PACS, DICOM, and HL7.
EchoGo Amyloidosis reports high diagnostic accuracy with 85% sensitivity and 93% specificity for identifying suspected cardiac amyloidosis, with consistent performance across CA subtypes. RhythmAnalytics has demonstrated cardiologist-level arrhythmia detection and classification with a sensitivity of 90.8% and a specificity of 98.2%.